Merit Medical Systems financials
$87.87+1.00%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.52B | $1.36B | $1.26B | $1.15B | $1.07B | $963.9M | $994.9M | $882.8M | $727.9M | $603.8M |
| Gross profit | $738.3M | $643.3M | $583.9M | $519.1M | $485.3M | $401.2M | $432.4M | $394.8M | $326.3M | $265.0M |
| Gross margin | 48.7% | 47.4% | 46.4% | 45.1% | 45.2% | 41.6% | 43.5% | 44.7% | 44.8% | 43.9% |
| Operating income | $184.7M | $155.7M | $123.9M | $87.6M | $60.9M | -$1.6M | $15.4M | $58.6M | $33.1M | $34.9M |
| Net income | $128.5M | $120.4M | $94.4M | $74.5M | $48.5M | -$9.8M | $5.5M | $42.0M | $27.5M | $20.1M |
| Net margin | 8.5% | 8.9% | 7.5% | 6.5% | 4.5% | −1.0% | 0.5% | 4.8% | 3.8% | 3.3% |
| Diluted EPS | $2.13 | $2.03 | $1.62 | $1.29 | $0.84 | $-0.18 | $0.10 | $0.78 | $0.55 | $0.45 |
| EBITDA | $307.9M | $258.4M | $215.7M | $178.3M | $174.2M | $152.7M | $131.6M | $128.8M | $99.3M | $79.2M |
| Operating cash flow | $297.4M | $220.8M | $145.2M | $114.3M | $147.2M | $165.3M | $77.8M | $86.5M | $62.7M | $53.6M |
| Free cash flow | $215.7M | $185.7M | $110.9M | $69.3M | $119.3M | $119.3M | -$360.0K | $23.2M | $24.1M | $20.8M |
| Diluted shares | 60.5M | 59.4M | 58.4M | 57.7M | 57.4M | 55.4M | 56.2M | 53.9M | 50.1M | 44.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $446.4M | $376.7M | $587.0M | $58.4M | $67.8M | $56.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $734.0M | $729.6M | $823.0M | $198.0M | $242.8M | $351.2M |
| Total assets | $2.69B | $2.42B | $2.33B | $1.66B | $1.65B | $1.66B |
| Total liabilities | $1.10B | $1.04B | $1.12B | $519.6M | $608.5M | $705.8M |
| Shareholders' equity | $1.58B | $1.38B | $1.20B | $1.14B | $1.04B | $958.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology